1. You are here:
  2. Research
  3. Research Articles
  4. 2011 Articles

2011 Articles

Liquid chromatography electrospray ionization tandem mass spectrometry for the detection of mesocarb abuse in horse doping.
Appolonova SA, Baranov PA, Mesonzhnik NV, Brazhnikova DO, Rodchenkov GM.
Drug Test. Anal., 2011, 3, 717–723.
Abstract

Easy stereoselective synthesis of 5α-estrane-3β,17α-diol, the major metabolite of nandrolone in the horse.
Balssa F, Fischer M, Bonnaire Y.
Steroids, 2011, 76, 667–668.
Abstract

Comparison of different liquid chromatography stationary phases in LC-HRMS metabolomics for the detection of recombinant growth hormone doping control.
Boyard-Kieken F, Dervilly-Pinel G, Garcia P, Paris AC, Popot MA, le Bizec B, Bonnaire Y.
J. Sep. Sci., 2011, 34, 3493–3501.
Abstract

Screen and confirmation of PEG-epoetin β in equine plasma.
Chang Y, Maylin GM, Matsumoto G, Neades SM, Catlin DH.
Drug Test. Anal., 2011, 3, 68–73.
Abstract

The use of in vitro technologies and high-resolution/accurate-mass LC-MS to screen for metabolites of 'designer' steroids in the equine.
Clarke A, Scarth J, Teale P, Pearce C, Hillyer L.
Drug Test. Anal., 2011, 3, 74–87.
Abstract

Determination of firocoxib in equine plasma using high performance liquid chromatography.
Cox S, Yarbrough J.
J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2011, 879, 205–208.
Abstract

The pharmacokinetics and in vitro cyclooxygenase selectivity of deracoxib in horses.
Davis JL, Marshall JF, Papich MG, Blikslager AT, Campbell NB.
J. Vet. Pharmacol. Ther., 2011, 34, 12–16.
Abstract

Pharmacokinetics and metabolism of dantrolene in horses.
DiMaio Knych HK, Arthur RM, Taylor A, Moeller BC, Stanley SD.
J. Vet. Pharmacol. Ther., 2011, 34, 238–46.
Abstract

Pharmacokinetics of yohimbine following intravenous administration to horses.
Dimaio Knych HK, Steffey EP, Deuel JL, Shepard RA, Stanley SD.
J. Vet. Pharmacol. Ther., 2011, 34, 58–63.
Abstract

Pharmacokinetics and pharmacodynamics of three intravenous doses of yohimbine in the horse.
Dimaio Knych HK, Steffey EP, Stanley SD.
J. Vet. Pharmacol. Ther., 2011, 34, 359–366.
Abstract

In vitro metabolism of tiletamine, zolazepam and nonbenzodiazepine sedatives: Identification of target metabolites for equine doping control.
Fenwick SJ, Scarth JP.
Drug Test. Anal., 2011, 3, 705–716.
Abstract

Evaluation of an extractionless high-performance liquid chromatography-tandem mass spectrometry method for detection and quantitation of rosiglitazone in canine plasma.
Frazier SA, McKemie DS, Guerrero TA, Skorupski KA, Rodriguez CO Jr.
Am. J. Vet. Res., 2011, 72, 263–70.
Abstract

Analysis of β-agonists by HPLC/ESI-MS(n) in horse doping control.
Garcia P, Paris AC, Gil J, Popot MA, Bonnaire Y.
Biomed. Chromatogr., 2011, 25, 147–154.
Abstract

Oral administration of tepoxalin in the horse: A PK/PD study.
Giorgi M, Cuniberti B, Ye G, Barbero R, Sgorbini M, Vercelli C, Corazza M, Re G.
Vet. J., 2011, 190, 143–149.
Abstract

Characterization of in vivo plasma metabolites of tepoxalin in horses using LC–MS–MS.
Giorgia M, Mengozzia G, Raffaellib A, Saba A.
J. Pharm. Biomed. Anal., 2011, 56, 45–53.
Abstract

The pharmacokinetics and pharmacodynamics of the injectable anaesthetic alfaxalone in the horse.
Goodwin WA, Keates HL, Pasloske K, Pearson M, Sauer B, Ranasinghe MG.
Vet. Anaesth. Analg., 2011, 38, 431–438.
Abstract

Analysis of methyloxime derivatives of intact esters of testosterone and boldenone in equine plasma using ultra high performance liquid chromatography tandem mass spectrometry.
Gray BP, Teale P, Pearce CM.
Drug Test. Anal., 2011, 3, 206–213.
Abstract

Doping control analysis of insulin and its analogues in equine urine by liquid chromatography-tandem mass spectrometry.
Ho EN, Wan TS, Wong AS, Lam KK, Stewart BD.
J. Chromatogr. A, 2011, 1218, 1139–1146.
Abstract

Simultaneous determination of codeine, ephedrine, guaiphenesin and chlorpheniramine in beagle dog plasma using high performance liquid chromatography coupled with tandem mass spectrometric detection: Application to a bioequivalence study.
Hu Z, Zou Q, Tian J, Sun L, Zhang Z.
J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2011, 879, 3937–3942.
Abstract

Advances in equine sports testing.
Kuuranne T.
Drug Test. Anal., 2011, 3, 18.
Abstract

Pharmacokinetics of methylphenidate after oral administration of immediate and sustained-release preparations in beagle dogs.
Lavy E, Prise U, Soldani G, Neri D, Brandriss N, Chaim AB, Giorgi M.
Vet. J., 2011, 189, 336–340.
Abstract

Identification of cryptorchidism in horses by analysing urine samples with gas chromatography/mass spectrometry.
Leung DKK, Tang FPW, Wan TSM.
Vet. J., 2011, 187, 60–64.
Abstract

Efficient use of retention time for the analysis of 302 drugs in equine plasma by LC-MS/MS with scheduled multiple reaction monitoring and instant library search.
Liu Y, Uboh CE, Soma LR, Li X, Guan F, You Y, Chen J.
Anal. Chem., 2011, 83, 6834–6841.
Abstract

Detection and confirmation of 60 anabolic and androgenic steroids in equine plasma by liquid chromatography-tandem mass spectrometry with instant library searching.
Liu Y, Uboh CE, Soma LR, Li X, Guan F, You Y, Rudy JA, Chen JW.
Drug Test. Anal., 2011, 3, 54–67.
Abstract

Analysis of gabapentin in equine plasma with measurement uncertainty estimation by liquid chromatography-tandem mass spectrometry.
Liu Y, Uboh CE, Soma LR, Li X, Guan F, You Y, Rudy JA, Chen JW.
J. Anal. Toxicol., 2011, 35, 75–84.
Abstract

Horse metabolism and the photocatalytic process as a tool to identify metabolic products formed from dopant substances: the case of sildenafil.
Medana C, Calza P, Giancotti V, Dal Bello F, Pasello E, Montana M, Baiocchi C.
Drug Test. Anal., 2011, 3, 724–734.
Abstract

Intravenous and sublingual buprenorphine in horses: pharmacokinetics and influence of sampling site.
Messenger KM, Davis JL, Lafevers DH, Barlow BM, Posner LP.
Vet. Anaesth. Analg., 2011, 38, 374–384.
Abstract

An interlaboratory study of the pharmacokinetics of testosterone following intramuscular administration to thoroughbred horses.
Moeller BC, Sams RA, Guinjab J, Szabo N, Colahan P, Stanley SD.
J. Vet. Pharmacol. Ther., 2011, 34, 588–593.
Abstract

The pharmacokinetics of levetiracetam in healthy dogs concurrently receiving phenobarbital.
Moore SA, Muñana KR, Papich MG, Nettifee-Osborne JA.
J. Vet. Pharmacol. Ther., 2011, 34, 31–34.
Abstract

Use of benchtop Exactive high resolution and high mass accuracy orbitrap mass spectrometer for screening in horse doping control.
Moulard Y, Bailly-Chouriberry L, Boyer S, Garcia P, Popot MA, Bonnaire Y.
Anal. Chim. Acta, 2011, 700, 126–136.
Abstract

Diazepam pharmacokinetics after nasal drop and atomized nasal administration in dogs.
Musulin SE, Mariani CL, Papich MG.
J. Vet. Pharmacol. Ther., 2011, 34, 17–24.
Abstract

Doping control in horses: housing conditions and oral recycling of flunixin by ingestion of contaminated straw.
Popot MA, Garcia P, Bonnaire Y.
J. Vet. Pharmacol. Ther., 2011, 34, 612–614.
Abstract

Validation of a liquid chromatography-tandem mass spectrometry method for quantification of glycopyrrolate in horse plasma.
Rumpler MJ, Sams RA, Colahan P
J. Anal. Toxicol., 2011, 35, 656–654.
Abstract

Pharmacokinetics of glycopyrrolate following intravenous administration in the horse.
Rumpler MJ, Sams RA, Colahan P.
J. Vet. Pharmacol. Ther., 2011, 34, 605–608.
Abstract

Simultaneous detection and quantification of parecoxib and valdecoxib in canine plasma by HPLC with spectrofluorimetric detection: development and validation of a new methodology.
Saccomanni G, Giorgi M, Del Carlo S, Manera C, Saba A, Macchia M.
Anal. Bioanal. Chem., 2011, 401, 1677–1684.
Abstract

Drug metabolism in the horse: a review.
Scarth JP, Teale P, Kuuranne T.
Drug Test. Anal., 2011, 3, 19–53.
Abstract

Plasma concentrations of testosterone and nandrolone in racing and nonracing intact male horses.
Soma LR, Uboh CE, You Y, Guan F, McDonnell S.
J. Vet. Pharmacol. Ther., 2011, 35, 132–138.
Abstract

Detection of various performance enhancing substances in specimens collected from race horses in Illinois: a five-year experience.
Taddei L, Benoit M, Sukta A, Peterson J, Gaensslen RE, Negrusz A.
J. Anal. Toxicol., 2011, 35, 438–443.
Abstract

The pharmacokinetics and metabolism of meloxicam in camels after intravenous administration.
Wasfi IA, Al Ali WA, Agha BA, Kamel AM, Al Biriki NA, Al Neaimi M.
J. Vet. Pharmacol. Ther., 2011, 35, 155–162.
Abstract

The pharmacokinetics of hydrochlorothiazide in the camel.
Wasfi IA, Al Katheeri NA.
J. Vet. Pharmacol. Ther., 2011, 34, 518–520.
Abstract

Elimination and phase II metabolism of ethanol in camels after intravenous administration.
Wasfi IA, Kamel AM, Saeed HM, Saleh NA, Wajid S, Al Katheeri NA, Agha BA.
Vet. J., 2011, 189, 95–99.
Abstract

Pharmacokinetics of pioglitazone after multiple oral dose administration in horses.
Wearn JM, Crisman MV, Davis JL, Geor RJ, Hodgson DR, Suagee JK, Ashraf-Khorassani M, McCutcheon LJ.
J. Vet. Pharmacol. Ther., 2011, 34, 252–258.
Abstract

A broad-spectrum equine urine screening method for free and enzyme-hydrolysed conjugated drugs with ultra performance liquid chromatography/tandem mass spectrometry.
Wong CHF, Tang FPW, Wan TSM.
Anal. Chim. Acta, 2011, 697, 48–60.
Abstract

In vitro metabolic studies using homogenized horse liver in place of horse liver microsomes.
Wong JKY, Tang FPW, Wan TSM.
Drug Test. Anal., 2011, 3, 393–399.
Abstract